Hitoshi Nakamura
Tohoku Pharmaceutical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hitoshi Nakamura.
European Journal of Pain | 2013
Sou Katsuyama; Hirokazu Mizoguchi; Hikari Kuwahata; Takaaki Komatsu; K. Nagaoka; Hitoshi Nakamura; Giacinto Bagetta; Tsukasa Sakurada; Shinobu Sakurada
β‐caryophyllene (BCP) is a common constitute of the essential oils of numerous spice, food plants and major component in Cannabis. The present study investigated the contribution of peripheral cannabinoid (CB) and opioid systems in the antinociception produced by intraplantar (i.pl.) injection of BCP. The interaction between peripheral BCP and morphine was also examined.
Biomedical Research-tokyo | 2015
Soh Katsuyama; Akira Otowa; Satomi Kamio; Kazuma Sato; Tomomi Yagi; Yukinaga Kishikawa; Takaaki Komatsu; Giacinto Bagetta; Tsukasa Sakurada; Hitoshi Nakamura
This study investigated the effect of bergamot essential oil (BEO) or linalool, a major volatile component of BEO, on the nociceptive response to formalin. Plantar subcutaneous injection of BEO or linalool into the ipsilateral hindpaw reduced both the first and late phases of the formalin-induced licking and biting responses in mice. Plantar subcutaneous injection of BEO or linalool into the contralateral hindpaw did not yield an antinociceptive effect, suggesting that the antinociceptive effect of BEO or linalool in the formalin test occurred peripherally. Intraperitoneal and plantar subcutaneous injection pretreatment with naloxone hydrochloride, an opioid receptor antagonist, significantly attenuated both BEO- and linalool-induced antinociception. Pretreatment with naloxone methiodide, a peripherally acting opioid receptor antagonists, also significantly antagonized the antinociceptive effects of BEO and linalool. Our results provide evidence for the involvement of peripheral opioids in antinociception induced by BEO and linalool. These results suggest that activation of peripheral opioid receptors may play an important role in reducing formalin-induced nociception.
International Scholarly Research Notices | 2014
Soh Katsuyama; Hiromu Aso; Akira Otowa; Tomomi Yagi; Yukinaga Kishikawa; Takaaki Komatsu; Tsukasa Sakurada; Hitoshi Nakamura
Vincristine is an anticancer drug used to treat a variety of cancer types, but it frequently causes peripheral neuropathy. Neuropathic pain is often associated with the appearance of abnormal sensory signs, such as allodynia. Milnacipran and duloxetine, serotonin/noradrenaline reuptake inhibitors, have shown efficacy against several chronic pain syndromes. In this study, we investigated the attenuation of vincristine-induced mechanical allodynia in mice by milnacipran and duloxetine. To induce peripheral neuropathy, vincristine was administered once per day (0.1 mg/kg, intraperitoneally (i.p.)) for 7 days. Mechanical allodynia was evaluated by measuring the withdrawal response to stimulation with a von Frey filament. In vincristine-treated mice, mechanical allodynia was observed on days 3–28 of vincristine administration. A single administration of milnacipran (40 mg/kg, i.p.) or duloxetine (20 mg/kg, i.p.) had no effect on vincristine-induced mechanical allodynia. However, repeated administration of milnacipran (20 or 40 mg/kg, once per day, i.p.) or duloxetine (5, 10, or 20 mg/kg, once per day, i.p.) for 7 days significantly reduced vincristine-induced mechanical allodynia. These results suggest that chronic vincristine administration induces mechanical allodynia, and that repeated milnacipran and duloxetine administration may be an effective approach for the treatment of neuropathic pain caused by vincristine treatment for cancer.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2016
Mieko Morone; Atsuko Sato; Isao Ohno; Yuichi Ohkawara; Tsuneyoshi Suzuki; Hitoshi Nakamura; Yutaka Azuma
In six-year pharmacy education programs, humanistic education is now regarded as more important than ever, and we are working to incorporate active learning methods into a variety of subjects. Because performance evaluations are by their nature subjective, it is difficult to ensure the validity of any given assessment. Fifth-year students at Tohoku Pharmaceutical University learn case and prescription analysis in problem-based learning tutorials. As part of this curriculum, 20 presentation and discussion meetings over the course of 10 weeks are held, with approximately 100 students making presentations two or more times each. With regard to the presentation skills that students are expected to acquire, we instructed them to conduct peer evaluations and analyzed the evaluation results for 863 students conducted between 2012 and 2014. From the results, it was found that peer evaluation scores improved between the first and second evaluations for 70% to 86% of students, and furthermore that students who received lower scores in their first evaluations increased their scores correspondingly in the second. In addition, while 87% of students responded positively in the presentation skill acquisition self-evaluations conducted after the completion of the program, there was no correlation between the results of self-evaluation and peer evaluation. It was suggested that many students were able to cultivate an eye for criticism by evaluating other students and gain confidence by becoming aware of their own growth through repeated presentations.
Japanese Journal of Pharmaceutical Health Care and Sciences | 2015
Yukihiro Noda; Ikuko Yano; Takao Aoyama; Michiru Watanabe; Ainari Konda; Hitoshi Nakamura; Ryo Matsushita; Kunihiko Morita; Katsushi Miyake; Hakaru Seo; Naoki Kamimura; Yoshihisa Tomioka; Junko Kizu; Mayumi Mochizuki
Yukihiro Noda 13, , Ikuko Yano 13, , Takao Aoyama 13, , Michiru Watanabe 13, , Ainari Konda , Hitoshi Nakamura , Ryo Matsushita 13, , Kunihiko Morita , Katsushi Miyake , Hakaru Seo 13, , Naoki Kamimura 13, , Yoshihisa Tomioka 13, , Junko Kizu 13, 14 and Mayumi Mochizuki 14 Faculty of Pharmacy, Meijo University , Graduate School of Pharmaceutical Sciences, Kyoto University , Faculty of Pharmaceutical Sciences, Tokyo University of Science , Faculty of Pharmacy, Musashino University , School of Pharmacy, Hokkaido Pharmaceutical University , Faculty of Pharmaceutical Sciences, Teikyo Heisei University , Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts , Faculty of Pharmaceutical Sciences, Hiroshima International University , Faculty of Pharmaceutical Sciences, Sojo University , Graduate School of Pharmaceutical Sciences, Tohoku University , Faculty of Pharmacy, Keio University , Japanese Society of Pharmacist Faculty in Pharmacy Schools 13
Chemical & Pharmaceutical Bulletin | 2005
Kenji Hoshi; Junko Kawakami; Mitiko Kumagai; Sanae Kasahara; Noriaki Nishimura; Hitoshi Nakamura; Kenichi Sato
Biomedical Research-tokyo | 2013
Soh Katsuyama; Kazuma Sato; Tomomi Yagi; Yukinaga Kishikawa; Hitoshi Nakamura
Biomedical Research-tokyo | 2012
Soh Katsuyama; Hikari Kuwahata; Tomomi Yagi; Yukinaga Kishikawa; Takaaki Komatsu; Tsukasa Sakurada; Hitoshi Nakamura
Chemical & Pharmaceutical Bulletin | 1970
Suminori Umio; Kazuo Kariyone; Kunihiko Tanaka; Teiji Kishimoto; Hitoshi Nakamura; Minoru Nishida
Chemical & Pharmaceutical Bulletin | 1969
Suminori Umio; Kazuo Kariyone; Kunihiko Tanaka; Hitoshi Nakamura